Syncom Formulations (India) Ltd
company logo

Syncom Formulations (India) Ltd

Syncom Formul. Share Price

Pharmaceuticals
Small Cap

-

0 (0%)


Invest in Syncom Formulations (India) Ltd
₹0 Brokerage*
Open Demat Account
*By signing up you agree to our Terms and Conditions

Syncom Formulations (India) Ltd Performance

-

-

-

-


-

-

-

-

-

Syncom Formulations (India) Ltd Fundamentals

Read More

1,853.68Cr

56.34

5.91

0.29

0.35

0%

3.34

Syncom Formulations (India) Ltd Financials

Syncom Formulations (India) Ltd Financialsright-arrow

Syncom Formulations (India) Ltd Shareholding Pattern

Syncom Formulations (India) Ltd Delivery and Volume

About Syncom Formulations (India) Ltd

Incorporated as a private limited company in 1988, Syncom Formulations (India) Limited was converted into a public limited company in Jun.'92. The Company in the Indian Pharmaceutical Industry represents synergistic combination of commitment and consistency. Syncom possesses the manufacturing streng

Vijay Shankarlal Bankda

1988

SYNCOMF

NameDesignation
Kedarmal BankdaChairman & Wholetime Director
Vijay Shankarlal BankdaManaging Director
Vinod Kumar KabraIndependent Director
Krishna Das NeemaIndependent Director
Praveen JindalIndependent Director
Rinki BankdaWhole-time Director
Ruchi JindalIndependent Director
Vaishali AgrawalCompany Sec. & Compli. Officer
Ritesh Kumar LunkadIndependent Director
Ankit JainIndependent Director
News and Events...

Similar Stocks

What's Trending

View All
View All

Syncom Formulations (India) Ltd FAQs

By opening a demat account and having your KYC papers confirmed online, you may simply purchase Syncom Formulations (India) Ltd shares in BlinkX.
The share price of any stock is volatile and changes during the day due to a variety of variables. Syncom Formulations (India) Ltd's share price is ₹19.77 as of 2024-11-21.
Syncom Formulations (India) Ltd's P/E ratio is 56.34 times as of 2024-11-21.
Syncom Formulations (India) Ltd's most recent financial reports indicate a price-to-book ratio of 5.91, showing the company's stock market valuation in relation to the value of its real assets.
Market capitalization, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Syncom Formulations (India) Ltd's market capitalization is ₹1853.68 Cr as on 2024-11-21.
The current financial records of Syncom Formulations (India) Ltd show a 8.71% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.
According to Syncom Formulations (India) Ltd's most recent financial filings, the company has a total asset value of ₹199.77, which includes current and non-current assets such as inventory, cash, properties, and equipment.
The 52-week high/low price of a Syncom Formulations (India) Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Syncom Formulations (India) Ltd's 52-week high and low as of 2024-11-21 are ₹20.28 and ₹19.6, respectively.